Published in J Clin Neurol on December 31, 2009
Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis (2008) 7.17
Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke (2001) 6.32
Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ (1997) 3.88
Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol (2007) 2.92
Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke (2003) 2.25
Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator--treated patients. Stroke (2003) 2.20
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology (2002) 2.02
Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology (1999) 1.93
Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology (2002) 1.79
The prognostic value of capillary glucose levels in acute stroke: the GLycemia in Acute Stroke (GLIAS) study. Stroke (2008) 1.77
Hyperglycemia in patients with focal cerebral ischemia after intravenous thrombolysis: influence on clinical outcome and infarct size. Cerebrovasc Dis (2002) 1.72
Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial. Stroke (2007) 1.70
Poststroke hyperglycemia: natural history and immediate management. Stroke (2003) 1.46
Stroke topography and outcome in relation to hyperglycaemia and diabetes. J Neurol Neurosurg Psychiatry (1992) 1.29
Hyperglycemia as an independent predictor of worse outcome in non-diabetic patients presenting with acute ischemic stroke. Neurocrit Care (2009) 1.20
Prevalence of admission hyperglycaemia across clinical subtypes of acute stroke. Lancet (1999) 1.19
A randomised, controlled pilot study to investigate the potential benefit of intervention with insulin in hyperglycaemic acute ischaemic stroke patients. Cerebrovasc Dis (2006) 1.15
Decreased mortality by normalizing blood glucose after acute ischemic stroke. Acad Emerg Med (2006) 1.11
Frequency and temporal profile of poststroke hyperglycemia using continuous glucose monitoring. Diabetes Care (2006) 0.99
Optimal blood glucose levels while using insulin to minimize the size of infarction in focal cerebral ischemia. J Neurosurg (2004) 0.98
IV insulin during acute cerebral infarction in diabetic patients. Neurology (2004) 0.85
Hyperglycaemia in acute stroke--to treat or not to treat. Cerebrovasc Dis (2009) 0.84
Blood glucose in acute stroke, different therapeutic targets for diabetic and non-diabetic patients? Acta Neurol Scand (2005) 0.83
Does hyperglycaemia play a role on the outcome of acute ischaemic stroke patients? J Neurol (1992) 0.83
Management of acute physiological parameters after stroke. QJM (2001) 0.80
An expedient phosphine-catalyzed [4 + 2] annulation: synthesis of highly functionalized tetrahydropyridines. J Am Chem Soc (2003) 1.89
Small-molecule inhibitors of protein geranylgeranyltransferase type I. J Am Chem Soc (2007) 1.72
An application of the phosphine-catalyzed [4 + 2] annulation in indole alkaloid synthesis: formal syntheses of (+/-)-alstonerine and (+/-)-macroline. Org Lett (2005) 1.47
Statistical MUNE: a comparison of two methods of setting recording windows in healthy subjects and ALS patients. Clin Neurophysiol (2007) 1.43
Phosphine-catalyzed [4 + 2] annulation: synthesis of cyclohexenes. J Am Chem Soc (2007) 1.38
Phosphine-catalyzed synthesis of 6-substituted 2-pyrones: manifestation of E/Z-isomerism in the zwitterionic intermediate. Org Lett (2005) 1.31
Phosphine-catalyzed synthesis of highly functionalized coumarins. Org Lett (2007) 1.31
Phosphine-catalyzed synthesis of 1,3-dioxan-4-ylidenes. Org Lett (2005) 1.29
Bisphosphine-catalyzed mixed double-Michael reactions: asymmetric synthesis of oxazolidines, thiazolidines, and pyrrolidines. J Am Chem Soc (2007) 1.25
Inhibitors of protein geranylgeranyltransferase I and Rab geranylgeranyltransferase identified from a library of allenoate-derived compounds. J Biol Chem (2008) 1.23
Theoretical rationale for regioselection in phosphine-catalyzed allenoate additions to acrylates, imines, and aldehydes. Org Lett (2006) 1.20
Stroke awareness decreases prehospital delay after acute ischemic stroke in Korea. BMC Neurol (2011) 1.18
Phosphine-promoted [3 + 3] annulations of aziridines with allenoates: facile entry into highly functionalized tetrahydropyridines. J Am Chem Soc (2009) 1.16
Advances in nucleophilic phosphine catalysis of alkenes, allenes, alkynes, and MBHADs. Chem Commun (Camb) (2013) 1.14
Current status of acute stroke management in Korea: a report on a multicenter, comprehensive acute stroke registry. Int J Stroke (2013) 1.13
Upbeat nystagmus: clinicoanatomical correlations in 15 patients. J Clin Neurol (2006) 1.11
In vivo antitumor effect of a novel inhibitor of protein geranylgeranyltransferase-I. Mol Cancer Ther (2009) 1.11
Alcohol-assisted phosphine catalysis: one-step syntheses of dihydropyrones from aldehydes and allenoates. Org Lett (2008) 1.10
In-hospital medical complications and long-term mortality after ischemic stroke. Stroke (2005) 1.03
Risk factors of intracranial cerebral atherosclerosis among asymptomatics. Cerebrovasc Dis (2007) 1.03
Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis. Stroke (2011) 1.03
Peroxisome proliferator-activated receptor-gamma-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia. Brain Res (2006) 1.03
Stable tetravalent phosphonium enolate zwitterions. J Am Chem Soc (2007) 1.03
Silicon-cored anthracene derivatives as host materials for highly efficient blue organic light-emitting devices. Adv Mater (2008) 1.02
Diversity through a branched reaction pathway: generation of multicyclic scaffolds and identification of antimigratory agents. Chemistry (2010) 1.02
Phosphine catalysis of allenes with electrophiles. Chem Soc Rev (2014) 1.02
Years of optimum health lost due to complications after acute ischemic stroke: disability-adjusted life-years analysis. Stroke (2010) 1.01
A torquoselective 6π electrocyclization approach to reserpine alkaloids. Org Lett (2012) 1.00
Phosphine-catalyzed annulations of azomethine imines: allene-dependent [3 + 2], [3 + 3], [4 + 3], and [3 + 2 + 3] pathways. J Am Chem Soc (2011) 0.99
Diversity through phosphine catalysis identifies octahydro-1,6-naphthyridin-4-ones as activators of endothelium-driven immunity. Proc Natl Acad Sci U S A (2011) 0.98
Reduced neurogenesis after suppressed inflammation by minocycline in transient cerebral ischemia in rat. J Neurol Sci (2009) 0.97
Burden of ischemic stroke in Korea: analysis of disability-adjusted life years lost. J Clin Neurol (2011) 0.97
Cluster-like Headache Secondary to Cerebral Venous Thrombosis. J Clin Neurol (2006) 0.97
Effect of ApoE genotype on response to donepezil in patients with Alzheimer's disease. Dement Geriatr Cogn Disord (2008) 0.97
Treatment outcomes of uterine artery embolization and laparoscopic uterine artery ligation for uterine myoma. Yonsei Med J (2003) 0.96
Two-photon fluorescent probes for intracellular free zinc ions in living tissue. Angew Chem Int Ed Engl (2008) 0.96
Cognitive impairment evaluated with Vascular Cognitive Impairment Harmonization Standards in a multicenter prospective stroke cohort in Korea. Stroke (2012) 0.95
Aplexone targets the HMG-CoA reductase pathway and differentially regulates arteriovenous angiogenesis. Development (2011) 0.95
Metronidazole-induced encephalopathy. J Neurol Sci (2004) 0.95
Reperfusion therapy in unclear-onset stroke based on MRI evaluation (RESTORE): a prospective multicenter study. Stroke (2012) 0.95
Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): a randomized double-blind non-inferiority trial. Cerebrovasc Dis (2011) 0.94
Phosphine-catalyzed β'-umpolung addition of nucleophiles to activated α-alkyl allenes. Org Lett (2011) 0.93
Diversity-oriented synthesis based on the DPPP-catalyzed mixed double-Michael reactions of electron-deficient acetylenes and β-amino alcohols. Molecules (2011) 0.91
PHOSPHINE-CATALYZED [4+2] ANNULATION: SYNTHESIS OF ETHYL 6-PHENYL-1-TOSYL-1,2,5,6-TETRAHYDROPYRIDINE-3-CARBOXYLATE. Organic Synth (2009) 0.91
Phosphine-initiated general base catalysis: facile access to benzannulated 1,3-diheteroatom five-membered rings via double-Michael reactions of allenes. Org Lett (2011) 0.90
Phosphine-catalyzed intramolecular γ-umpolung addition of α-aminoalkylallenic esters: facile synthesis of 3-carbethoxy-2-alkyl-3-pyrrolines. Chem Commun (Camb) (2012) 0.90
Retained placenta accreta after a first-trimester abortion manifesting as an uterine mass. Obstet Gynecol Sci (2013) 0.90
Association between changes in lipid profiles and progression of symptomatic intracranial atherosclerotic stenosis: a prospective multicenter study. Stroke (2012) 0.89
Theoretical calculations and vibrational spectra of 1,4-benzodioxan in its S(1)(pi, pi*) electronic excited state. Spectrochim Acta A Mol Biomol Spectrosc (2007) 0.89
Activation of the gluteus maximus and hamstring muscles during prone hip extension with knee flexion in three hip abduction positions. Man Ther (2013) 0.89
Development of optical fiber Bragg grating force-reflection sensor system of medical application for safe minimally invasive robotic surgery. Rev Sci Instrum (2011) 0.87
Substituent effect on the luminescent properties of a series of deep blue emitting mixed ligand Ir(III) complexes. J Phys Chem B (2006) 0.87
Theory-Guided Design of Brønsted Acid-Assisted Phosphine Catalysis: Synthesis of Dihydropyrones from Aldehydes and Allenoates. Tetrahedron (2008) 0.87
Phosphine-catalyzed [4+2] annulations of 2-alkylallenoates and olefins: synthesis of multisubstituted cyclohexenes. Chem Asian J (2011) 0.87
Correlation of coronary and cerebral atherosclerosis: difference between extracranial and intracranial arteries. Cerebrovasc Dis (2005) 0.86
Total synthesis of (±)-hirsutine: application of phosphine-catalyzed imine-allene [4 + 2] annulation. Org Lett (2012) 0.85
Analysis of the occupational stress of Korean surgeons: a pilot study. J Korean Surg Soc (2013) 0.85
Metal-ion sensing fluorophores with large two-photon absorption cross sections: aza-crown ether substituted donor-acceptor-donor distyrylbenzenes. J Am Chem Soc (2004) 0.85
Macrolactones in diversity-oriented synthesis: preparation of a pilot library and exploration of factors controlling macrocyclization. J Comb Chem (2004) 0.84
Hydroxyproline-derived pseudoenantiomeric [2.2.1] bicyclic phosphines: asymmetric synthesis of (+)- and (-)-pyrrolines. J Am Chem Soc (2014) 0.84
Synthesis of the [5-7-6] tricyclic core of guanacastepene A via an intramolecular Mukaiyama aldol reaction. Org Lett (2003) 0.84
In vitro and in vivo effects of geranylgeranyltransferase I inhibitor P61A6 on non-small cell lung cancer cells. BMC Cancer (2013) 0.84
Enantioselective total synthesis of (+)-ibophyllidine via an asymmetric phosphine-catalyzed [3 + 2] annulation. Chem Sci (2012) 0.84
Nighttime blood pressure and white matter hyperintensities in patients with Parkinson disease. Chronobiol Int (2013) 0.83
Equilibrium between a vinylogous ylide and a phosphonium dienolate zwitterion: vinylogous Wittig olefination versus vinylogous aldol-type reaction. Tetrahedron (2010) 0.83
Ipsilateral hemiparesis caused by a corona radiata infarct after a previous stroke on the opposite side. Arch Neurol (2005) 0.83
Identification and characterization of mechanism of action of P61-E7, a novel phosphine catalysis-based inhibitor of geranylgeranyltransferase-I. PLoS One (2011) 0.83
Gender-specific influence of socioeconomic status on the prevalence of migraine and tension-type headache: the results from the Korean Headache Survey. J Headache Pain (2013) 0.83
Origins of 1,6-stereoinduction in torquoselective 6π electrocyclizations. J Am Chem Soc (2013) 0.83
Tandem 6pi-electrocyclization and cycloaddition of nitrodienes to yield multicyclic nitroso acetals. J Am Chem Soc (2010) 0.83
Liver enzymes and vitamin D levels in metabolically healthy but obese individuals: Korean National Health and Nutrition Examination Survey. Metabolism (2013) 0.82
Predictors of recurrent stroke in patients with symptomatic intracranial arterial stenosis. Stroke (2012) 0.82
Phosphine/palladium-catalyzed syntheses of alkylidene phthalans, 3-deoxyisoochracinic acid, isoochracinic acid, and isoochracinol. Org Lett (2012) 0.82
Gender differences in the age-stratified prevalence of risk factors in Korean ischemic stroke patients: a nationwide stroke registry-based cross-sectional study. Int J Stroke (2013) 0.82
Inter- and intra-individual variations of urinary endogenous metabolites in healthy male college students using (1)H NMR spectroscopy. Clin Chem Lab Med (2009) 0.81
Flow cytometry enables a high-throughput homogeneous fluorescent antibody-binding assay for cytotoxic T cell lytic granule exocytosis. J Biomol Screen (2012) 0.81
Two-photon fluorescent probes for acidic vesicles in live cells and tissue. Angew Chem Int Ed Engl (2008) 0.81
Fluorescence and ultraviolet absorption spectra and structure of coumaran and its ring-puckering potential energy function in the S1(pi,pi*) excited state. J Chem Phys (2006) 0.81
Laparoscopic hernia sac transection and intracorporeal ligation show very low recurrence rate in pediatric inguinal hernia. J Laparoendosc Adv Surg Tech A (2012) 0.80
Validation of minor stroke definitions for thrombolysis decision making. J Stroke Cerebrovasc Dis (2013) 0.80
Chiral aminophosphines as catalysts for enantioselective double-Michael indoline syntheses. Molecules (2012) 0.79
Heteroleptic platinum(II) complexes of 8-quinolinolates bearing electron withdrawing groups in 5-position. Dalton Trans (2008) 0.79
Screening of the A11084G Polymorphism and Scanning of a Mitochondrial Genome SNP in Korean Migraineurs. J Clin Neurol (2007) 0.79
Primary medullary hemorrhage associated with hypertension. J Clin Neurol (2005) 0.79
Effect of rivastigmine or memantine add-on therapy is affected by butyrylcholinesterase genotype in patients with probable Alzheimer's disease. Eur Neurol (2014) 0.78
Weekend admission in patients with acute ischemic stroke is not associated with poor functional outcome than weekday admission. J Clin Neurol (2012) 0.78
One-pot phosphine-catalyzed syntheses of quinolines. J Org Chem (2012) 0.78
Greater stroke severity predominates over all other factors for the worse outcome of cardioembolic stroke. J Stroke Cerebrovasc Dis (2013) 0.78